Search Result

Results for "

bacterial bronchitis

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Bacterial (13) 5-HT Receptor (3) Antibiotic (12) Beta-lactamase (1) Isotope-Labeled Compounds (4) Penicillin-binding protein (PBP) (3)
By Research Areas:	Cancer (6) Infection (14) Inflammation/Immunology (4) Neurological Disease (3)

Inhibitors & Agonists

Isotope-Labeled Compounds

Targets Recommended: Bacterial

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-66011

Moxifloxacin Hydrochloride Maximum Cited Publications 7 Publications Verification BAY 12-8039	Bacterial Antibiotic	Infection Cancer
Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia .

HY-B0198

Cefaclor 1 Publications Verification	Antibiotic Penicillin-binding protein (PBP) Bacterial 5-HT Receptor	Infection Neurological Disease Inflammation/Immunology
Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections .

HY-B0198A

Cefaclor monohydrate 1 Publications Verification	Antibiotic Bacterial Penicillin-binding protein (PBP) 5-HT Receptor	Infection Neurological Disease Inflammation/Immunology
Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections .

HY-66011A

Moxifloxacin Maximum Cited Publications 7 Publications Verification BAY 12-8039 free base	Bacterial Antibiotic	Infection Cancer
Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia .

HY-135398

Decarboxy Moxifloxacin	Bacterial	Infection Inflammation/Immunology
Decarboxy Moxifloxacin (compound 8) is a decarboxylated compound of Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .

HY-B0198R

Cefaclor (Standard)	Antibiotic Penicillin-binding protein (PBP) Bacterial 5-HT Receptor	Infection Neurological Disease Inflammation/Immunology
Cefaclor (Standard) is the analytical standard of Cefaclor. This product is intended for research and analytical applications. Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections .

HY-66011AS

Moxifloxacin-d4 BAY 12-8039-d₄ free base	Isotope-Labeled Compounds Bacterial Antibiotic	Infection
Moxifloxacin-d₄ is the deuterium labeled Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2].

HY-66011AS2

Moxifloxacin-d3 hydrochloride BAY 12-8039-d₃	Bacterial Antibiotic	Infection Cancer
Moxifloxacin-d₃ (hydrochloride) is the deuterium labeled Moxifloxacin hydrochloride. Moxifloxacin hydrochloride is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2][3].

HY-66011AR

Moxifloxacin (Standard)	Bacterial Antibiotic	Infection Cancer
Moxifloxacin (Standard) is the analytical standard of Moxifloxacin. This product is intended for research and analytical applications. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia .

HY-66011S

rac cis-Moxifloxacin-d4 hydrochloride rac cis-BAY 12-8039-d₄	Isotope-Labeled Compounds Bacterial Antibiotic	Infection
rac cis-Moxifloxacin-d₄ (hydrochloride) is the deuterium labeled Moxifloxacin hydrochloride. Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2].

HY-66011B

(Rac)-Moxifloxacin (Rac)-BAY 12-8039 free base	Bacterial Antibiotic	Infection
(Rac)-Moxifloxacin ((Rac)-BAY 12-8039 free base) is the isoform of Moxifloxacin Hydrochloride (HY-66011), which is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia .

HY-66011R

Moxifloxacin Hydrochloride (Standard) BAY 12-8039 (Standard)	Bacterial Antibiotic	Infection Cancer
Moxifloxacin (Hydrochloride) (Standard) is the analytical standard of Moxifloxacin (Hydrochloride). This product is intended for research and analytical applications. Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia .

HY-66011AS3

Moxifloxacin-d3-1 hydrochloride BAY 12-8039-d₃-1	Isotope-Labeled Compounds	Infection
Moxifloxacin-d₃-1 hydrochloride (BAY 12-8039-d₃-1) is a deuterium labeled Moxifloxacin (HY-66011A). Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia .

HY-66011AS4

Moxifloxacin-13C,d3 hydrochloride BAY 12-8039-¹³C,d₃	Isotope-Labeled Compounds	Cancer
Moxifloxacin- ¹³C,d₃ hydrochloride (BAY 12-8039- ¹³C,d₃) is ¹³C and deuterated labeled Moxifloxacin (HY-66011A). Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia.

HY-19964

Potassium clavulanate cellulose 2 Publications Verification Potassium clavulanate:cellulose (1:1)	Beta-lactamase Bacterial Antibiotic	Infection
Potassium clavulanate cellulose (Potassium clavulanate:cellulose (1:1)) is a mixture of potassium clavulanate and cellulose, is a bacterial β-lactamase inhibitor. Clavulanate potassium is a form of Clavulanic acid. Clavulanate potassium fights bacteria that resistant to penicillins and other antibiotics. Potassium clavulanate with the combination of amoxicillin can be used for the research of different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin .

Cat. No.	Product Name	Chemical Structure

HY-66011AS

Moxifloxacin-d4
Moxifloxacin-d₄ is the deuterium labeled Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2].

HY-66011AS2

Moxifloxacin-d3 hydrochloride
Moxifloxacin-d₃ (hydrochloride) is the deuterium labeled Moxifloxacin hydrochloride. Moxifloxacin hydrochloride is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2][3].

HY-66011S

rac cis-Moxifloxacin-d4 hydrochloride
rac cis-Moxifloxacin-d₄ (hydrochloride) is the deuterium labeled Moxifloxacin hydrochloride. Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2].

HY-66011AS3

Moxifloxacin-d3-1 hydrochloride
Moxifloxacin-d₃-1 hydrochloride (BAY 12-8039-d₃-1) is a deuterium labeled Moxifloxacin (HY-66011A). Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia .

HY-66011AS4

Moxifloxacin-13C,d3 hydrochloride
Moxifloxacin- ¹³C,d₃ hydrochloride (BAY 12-8039- ¹³C,d₃) is ¹³C and deuterated labeled Moxifloxacin (HY-66011A). Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute *bacterial* sinusitis, acute *bacterial* exacerbations of chronic bronchitis, and community-acquired pneumonia.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.